More Fusen Pharmaceutical Co., Ltd. news
Fusen Pharmaceutical Co., Ltd.HKEX: 1652

Interim Report 2026

Sep 30, 2026 at 8:33 AM UTC · Issued by Fusen Pharmaceutical Co., Ltd. via HKEXnews

HKEX: 1652

View Attachment

View original source (HKEXnews)

Earlier from Fusen Pharmaceutical

  • Fusen Pharmaceutical: PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS, RE-APPOINTMENT OF AUDITORS, DECLARATION OF FINAL DIVIDEND, AMENDMENTS TO THE MEMORANDUM AND THE ARTICLES, ADOPTION OF THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL GENERAL MEETINGApr 28, 2022
  • Fusen Pharmaceutical: APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORAug 13, 2020
All Fusen Pharmaceutical news releases↗